The FDA’s Oncology Center of Excellence — Quantifying the Patient Expe

The Oncology Center of Excellence Patient-Focused Drug Development Program engages cancer patients and advocacy groups, and encourages research into the measurement of patient experiences to generate science-based recommendations for patient-centered regulatory policy.

Read the full article here

Related Articles